Overview
- Accenture said more than 400 AI specialists from Faculty will join its workforce to deepen decision intelligence and AI safety capabilities.
- Faculty’s Frontier platform will become part of Accenture’s product suite, with existing deployments such as work with Novartis to improve clinical trial planning.
- The deal requires regulatory approvals before closing, and Accenture did not disclose financial terms.
- Several outlets reported a valuation of about $1 billion, though Accenture has not confirmed the figure.
- Warner will join Accenture’s Global Management Committee, and Accenture plans to extend Faculty’s Fellowship talent program globally; coverage also notes Faculty’s NHS early‑warning work and past links to Vote Leave.